US Patent 9,890,141 — assignment history and current owner
US 9,890,141 · Application 15/144,892
Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof
Who owns US Patent 9,890,141?
US9890141 ("Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof") — current assignee: BAUSCH + LOMB IRELAND LIMITED. Status: Active, estimated expiration October 21, 2030. 8 recorded USPTO assignments.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 9,890,141 is BAUSCH + LOMB IRELAND LIMITED. Based on the most recent ownership transfer record (recorded 2023-12-06).
- Patent title
- Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof
- Application number
- 15/144,892
- Apparent operating assignee
- BAUSCH + LOMB IRELAND LIMITED
- Patent status
- Active, estimated expiration October 21, 2030
- Recorded assignments
- 8
Note: security interests appear active (JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT; CITIBANK, N.A., AS NOTES COLLATERAL AGENT) with no recorded release. Security interests reflect financing arrangements, not operating ownership.
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Dec 14, 2010 | May 2, 2017 | Ownership Transfer | BURNIER, JOHN | SARCODE CORPORATION | 42208/520 |
| Jul 15, 2011 | May 2, 2017 | Name Change | SARCODE CORPORATION | SARCODE BIOSCIENCE INC. | 42385/46 |
| Jul 1, 2019 | Oct 31, 2019 | Ownership Transfer | SARCODE BIOSCIENCE INC. | NOVARTIS AG | 50900/268 |
| Oct 21, 2020 | Oct 22, 2020 | Ownership Transfer | NOVARTIS AG | NOVARTIS PHARMACEUTICALS CORPORATION | 54134/708 |
| Sep 29, 2023 | Dec 6, 2023 | Ownership Transfer | NOVARTIS PHARMACEUTICALS CORPORATION | BAUSCH + LOMB IRELAND LIMITED | 65789/853 |
| Dec 18, 2025 | Dec 23, 2025 | Security Agreement | BAUSCH + LOMB IRELAND LIMITED | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 74050/573 |
| Dec 18, 2025 | Dec 23, 2025 | Security Agreement | BAUSCH + LOMB IRELAND LIMITED | CITIBANK, N.A., AS NOTES COLLATERAL AGENT | 74050/682 |
| Dec 18, 2025 | Dec 23, 2025 | Security Agreement | BAUSCH + LOMB IRELAND LIMITED | CITIBANK, N.A., AS NOTES COLLATERAL AGENT | 74050/709 |
Scrolls sideways on narrow screens
Chain of title
In 2017, BURNIER, JOHN assigned the patent to SARCODE CORPORATION. The most recent ownership transfer, recorded in 2023, lists BAUSCH + LOMB IRELAND LIMITED as assignee. In 2017, SARCODE CORPORATION changed its name to SARCODE BIOSCIENCE INC.. In 2025, JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
Ownership settled? Give your AI the file.
Application 15/144,892 · US 9,890,141
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 9,890,141, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.